(Q51471258)

English

Chromium picolinate and biotin combination improves glucose metabolism in treated, uncontrolled overweight to obese patients with type 2 diabetes.

scientific article published in January 2008

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

5 April 2018

http://europepmc.org/abstract/MED/17506119

Chromium picolinate and biotin combination improves glucose metabolism in treated, uncontrolled overweight to obese patients with type 2 diabetes. (English)

1 reference

Europe PubMed Central

PubMed publication ID

5 April 2018

http://europepmc.org/abstract/MED/17506119

type 2 diabetes

0 references

0 references

Joseph L. Evans

object named as

Joseph L Evans

3

0 references

author name string

Cesar A Albarracin

1

1 reference

Europe PubMed Central

PubMed publication ID

5 April 2018

http://europepmc.org/abstract/MED/17506119

Burcham C Fuqua

2

1 reference

Europe PubMed Central

PubMed publication ID

5 April 2018

http://europepmc.org/abstract/MED/17506119

Ira D Goldfine

4

1 reference

Europe PubMed Central

PubMed publication ID

5 April 2018

http://europepmc.org/abstract/MED/17506119

publication date

1 January 2008

1 reference

Europe PubMed Central

PubMed publication ID

5 April 2018

http://europepmc.org/abstract/MED/17506119

Diabetes - Metabolism: Research and Reviews

1 reference

Europe PubMed Central

PubMed publication ID

5 April 2018

http://europepmc.org/abstract/MED/17506119

24

1 reference

Europe PubMed Central

PubMed publication ID

5 April 2018

http://europepmc.org/abstract/MED/17506119

1

1 reference

Europe PubMed Central

PubMed publication ID

5 April 2018

http://europepmc.org/abstract/MED/17506119

41-51

1 reference

Europe PubMed Central

PubMed publication ID

5 April 2018

http://europepmc.org/abstract/MED/17506119

Pharmacologic therapy for type 2 diabetes mellitus

1 reference

https://api.crossref.org/works/10.1002%2FDMRR.755

21 January 2018

Chromium research from a distance: from 1959 to 1980.

1 reference

https://api.crossref.org/works/10.1002%2FDMRR.755

21 January 2018

Use of Metabolic Markers To Identify Overweight Individuals Who Are Insulin Resistant

1 reference

https://api.crossref.org/works/10.1002%2FDMRR.755

21 January 2018

Chromium picolinate positively influences the glucose transporter system via affecting cholesterol homeostasis in adipocytes cultured under hyperglycemic diabetic conditions

1 reference

https://api.crossref.org/works/10.1002%2FDMRR.755

21 January 2018

Chromium, Glucose Intolerance and Diabetes

1 reference

https://api.crossref.org/works/10.1002%2FDMRR.755

21 January 2018

Global and societal implications of the diabetes epidemic

1 reference

https://api.crossref.org/works/10.1002%2FDMRR.755

7 January 2021

based on heuristic

inferred from DOI database lookup

Banting lecture 1988. Role of insulin resistance in human disease

1 reference

https://api.crossref.org/works/10.1002%2FDMRR.755

7 January 2021

based on heuristic

inferred from DOI database lookup

Childhood obesity: a new pandemic of the new millennium

1 reference

https://api.crossref.org/works/10.1002%2FDMRR.755

7 January 2021

based on heuristic

inferred from DOI database lookup

Prevalence of overweight and obesity among US children, adolescents, and adults, 1999-2002.

1 reference

https://api.crossref.org/works/10.1002%2FDMRR.755

7 January 2021

based on heuristic

inferred from DOI database lookup

Childhood obesity

1 reference

https://api.crossref.org/works/10.1002%2FDMRR.755

7 January 2021

based on heuristic

inferred from DOI database lookup

Use of chromium picolinate and biotin in the management of type 2 diabetes: an economic analysis

1 reference

https://api.crossref.org/works/10.1002%2FDMRR.755

7 January 2021

based on heuristic

inferred from DOI database lookup

Controlling spending for prescription drugs

1 reference

https://api.crossref.org/works/10.1002%2FDMRR.755

7 January 2021

based on heuristic

inferred from DOI database lookup

Role of chromium in human health and in diabetes

1 reference

https://api.crossref.org/works/10.1002%2FDMRR.755

7 January 2021

based on heuristic

inferred from DOI database lookup

Chromium(III) and the glucose tolerance factor

1 reference

https://api.crossref.org/works/10.1002%2FDMRR.755

7 January 2021

based on heuristic

inferred from DOI database lookup

Oral chromium picolinate improves carbohydrate and lipid metabolism and enhances skeletal muscle Glut-4 translocation in obese, hyperinsulinemic (JCR-LA corpulent) rats

1 reference

https://api.crossref.org/works/10.1002%2FDMRR.755

7 January 2021

based on heuristic

inferred from DOI database lookup

Chromium picolinate supplementation improves insulin sensitivity in Goto-Kakizaki diabetic rats

1 reference

https://api.crossref.org/works/10.1002%2FDMRR.755

7 January 2021

based on heuristic

inferred from DOI database lookup

Insulin sensitising action of chromium picolinate in various experimental models of diabetes mellitus

1 reference

https://api.crossref.org/works/10.1002%2FDMRR.755

7 January 2021

based on heuristic

inferred from DOI database lookup

Chromium picolinate enhances skeletal muscle cellular insulin signaling in vivo in obese, insulin-resistant JCR:LA-cp rats

1 reference

https://api.crossref.org/works/10.1002%2FDMRR.755

7 January 2021

based on heuristic

inferred from DOI database lookup

Chromium picolinate supplementation attenuates body weight gain and increases insulin sensitivity in subjects with type 2 diabetes

1 reference

https://api.crossref.org/works/10.1002%2FDMRR.755

7 January 2021

based on heuristic

inferred from DOI database lookup

Chromium as a supplement

1 reference

https://api.crossref.org/works/10.1002%2FDMRR.755

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical studies on chromium picolinate supplementation in diabetes mellitus--a review

1 reference

https://api.crossref.org/works/10.1002%2FDMRR.755

7 January 2021

based on heuristic

inferred from DOI database lookup

Glucose and insulin responses to dietary chromium supplements: a meta-analysis

1 reference

https://api.crossref.org/works/10.1002%2FDMRR.755

7 January 2021

based on heuristic

inferred from DOI database lookup

Chromium treatment has no effect in patients with poorly controlled, insulin-treated type 2 diabetes in an obese Western population: a randomized, double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1002%2FDMRR.755

7 January 2021

based on heuristic

inferred from DOI database lookup

Chromium Picolinate Intake and Risk of Type 2 Diabetes: An Evidence-Based Review by the United States Food and Drug Administration

1 reference

https://api.crossref.org/works/10.1002%2FDMRR.755

7 January 2021

based on heuristic

inferred from DOI database lookup

Chromium supplementation does not improve glucose tolerance, insulin sensitivity, or lipid profile: a randomized, placebo-controlled, double-blind trial of supplementation in subjects with impaired glucose tolerance: response to Gunton et al.

1 reference

https://api.crossref.org/works/10.1002%2FDMRR.755

7 January 2021

based on heuristic

inferred from DOI database lookup

Chromium supplementation does not improve glucose tolerance, insulin sensitivity, or lipid profile: a randomized, placebo-controlled, double-blind trial of supplementation in subjects with impaired glucose tolerance

1 reference

https://api.crossref.org/works/10.1002%2FDMRR.755

7 January 2021

based on heuristic

inferred from DOI database lookup

Elevated intakes of supplemental chromium improve glucose and insulin variables in individuals with type 2 diabetes

1 reference

https://api.crossref.org/works/10.1002%2FDMRR.755

7 January 2021

based on heuristic

inferred from DOI database lookup

Stability and absorption of chromium and absorption of chromium histidinate complexes by humans

1 reference

https://api.crossref.org/works/10.1002%2FDMRR.755

7 January 2021

based on heuristic

inferred from DOI database lookup

Pharmacological effects of biotin

1 reference

https://api.crossref.org/works/10.1002%2FDMRR.755

7 January 2021

based on heuristic

inferred from DOI database lookup

High-dose biotin, an inducer of glucokinase expression, may synergize with chromium picolinate to enable a definitive nutritional therapy for type II diabetes.

1 reference

https://api.crossref.org/works/10.1002%2FDMRR.755

7 January 2021

based on heuristic

inferred from DOI database lookup

Biotin administration improves the impaired glucose tolerance of streptozotocin-induced diabetic Wistar rats

1 reference

https://api.crossref.org/works/10.1002%2FDMRR.755

7 January 2021

based on heuristic

inferred from DOI database lookup

A high biotin diet improves the impaired glucose tolerance of long-term spontaneously hyperglycemic rats with non-insulin-dependent diabetes mellitus

1 reference

https://api.crossref.org/works/10.1002%2FDMRR.755

7 January 2021

based on heuristic

inferred from DOI database lookup

Biotin supplementation improves glucose and insulin tolerances in genetically diabetic KK mice

1 reference

https://api.crossref.org/works/10.1002%2FDMRR.755

7 January 2021

based on heuristic

inferred from DOI database lookup

Biotin supplementation reduces plasma triacylglycerol and VLDL in type 2 diabetic patients and in nondiabetic subjects with hypertriglyceridemia

1 reference

https://api.crossref.org/works/10.1002%2FDMRR.755

7 January 2021

based on heuristic

inferred from DOI database lookup

The effect of chromium picolinate and biotin supplementation on glycemic control in poorly controlled patients with type 2 diabetes mellitus: a placebo-controlled, double-blinded, randomized trial

1 reference

https://api.crossref.org/works/10.1002%2FDMRR.755

7 January 2021

based on heuristic

inferred from DOI database lookup

Is there a simple way to identify insulin-resistant individuals at increased risk of cardiovascular disease?

1 reference

https://api.crossref.org/works/10.1002%2FDMRR.755

7 January 2021

based on heuristic

inferred from DOI database lookup

Lower baseline glycemia reduces apparent oral agent glucose-lowering efficacy: a meta-regression analysis

1 reference

https://api.crossref.org/works/10.1002%2FDMRR.755

7 January 2021

based on heuristic

inferred from DOI database lookup

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group

1 reference

https://api.crossref.org/works/10.1002%2FDMRR.755

7 January 2021

based on heuristic

inferred from DOI database lookup

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group

1 reference

https://api.crossref.org/works/10.1002%2FDMRR.755

7 January 2021

based on heuristic

inferred from DOI database lookup

Protein-tyrosine phosphatase-1B acts as a negative regulator of insulin signal transduction

1 reference

https://api.crossref.org/works/10.1002%2FDMRR.755

7 January 2021

based on heuristic

inferred from DOI database lookup

Increased insulin sensitivity and obesity resistance in mice lacking the protein tyrosine phosphatase-1B gene

1 reference

https://api.crossref.org/works/10.1002%2FDMRR.755

7 January 2021

based on heuristic

inferred from DOI database lookup

Increased energy expenditure, decreased adiposity, and tissue-specific insulin sensitivity in protein-tyrosine phosphatase 1B-deficient mice

1 reference

https://api.crossref.org/works/10.1002%2FDMRR.755

7 January 2021

based on heuristic

inferred from DOI database lookup

Protein tyrosine phosphatases: their role in insulin action and potential as drug targets.

1 reference

https://api.crossref.org/works/10.1002%2FDMRR.755

7 January 2021

based on heuristic

inferred from DOI database lookup

Protein-tyrosine phosphatase 1B (PTP1B): a novel therapeutic target for type 2 diabetes mellitus, obesity and related states of insulin resistance

1 reference

https://api.crossref.org/works/10.1002%2FDMRR.755

7 January 2021

based on heuristic

inferred from DOI database lookup

Protein tyrosine phosphatase 1B: a novel target for type 2 diabetes and obesity

1 reference

https://api.crossref.org/works/10.1002%2FDMRR.755

7 January 2021

based on heuristic

inferred from DOI database lookup

New azolidinediones as inhibitors of protein tyrosine phosphatase 1B with antihyperglycemic properties

1 reference

https://api.crossref.org/works/10.1002%2FDMRR.755

7 January 2021

based on heuristic

inferred from DOI database lookup

Discovery of a novel protein tyrosine phosphatase-1B inhibitor, KR61639: potential development as an antihyperglycemic agent

1 reference

https://api.crossref.org/works/10.1002%2FDMRR.755

7 January 2021

based on heuristic

inferred from DOI database lookup

Discovery and Structure−Activity Relationship of Oxalylarylaminobenzoic Acids as Inhibitors of Protein Tyrosine Phosphatase 1B

1 reference

https://api.crossref.org/works/10.1002%2FDMRR.755

7 January 2021

based on heuristic

inferred from DOI database lookup

Cellular chromium enhances activation of insulin receptor kinase

1 reference

https://api.crossref.org/works/10.1002%2FDMRR.755

7 January 2021

based on heuristic

inferred from DOI database lookup

Regulation of insulin receptor function by a small molecule insulin receptor activator.

1 reference

https://api.crossref.org/works/10.1002%2FDMRR.755

7 January 2021

based on heuristic

inferred from DOI database lookup

Decreased insulin receptor (IR) autophosphorylation in fibroblasts from patients with PCOS: effects of serine kinase inhibitors and IR activators.

1 reference

https://api.crossref.org/works/10.1002%2FDMRR.755

7 January 2021

based on heuristic

inferred from DOI database lookup

Chromium activates glucose transporter 4 trafficking and enhances insulin-stimulated glucose transport in 3T3-L1 adipocytes via a cholesterol-dependent mechanism

1 reference

https://api.crossref.org/works/10.1002%2FDMRR.755

7 January 2021

based on heuristic

inferred from DOI database lookup

Glucokinase, glucose homeostasis, and diabetes mellitus

1 reference

https://api.crossref.org/works/10.1002%2FDMRR.755

7 January 2021

based on heuristic

inferred from DOI database lookup

Biotin--a regulator of gene expression

1 reference

https://api.crossref.org/works/10.1002%2FDMRR.755

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1002/DMRR.755

1 reference

Europe PubMed Central

PubMed publication ID

5 April 2018

http://europepmc.org/abstract/MED/17506119

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

5 April 2018

http://europepmc.org/abstract/MED/17506119

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q51471258&oldid=1446616699"